Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001193125-26-016934 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 20, 2026 |
| Document Date | Jan 20, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
16,500
Total Value
$589,871.12
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 20, 2026 | Exercise/Conversion | 3,000 | $31.20 | $93,600.00 | 3,000 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 20, 2026 | Exercise/Conversion | 2,500 | $49.10 | $122,750.00 | 5,500 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 20, 2026 | Sale | 400 | $66.68 | $26,672.00 | 5,100 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 20, 2026 | Sale | 4,900 | $67.99 | $333,145.12 | 200 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 20, 2026 | Sale | 200 | $68.52 | $13,704.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 20, 2026 | Exercise/Conversion | 3,000 | $0.00 | $0.00 | 10,000 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 20, 2026 | Exercise/Conversion | 2,500 | $0.00 | $0.00 | 5,000 | Direct | โ | View Details |